Want to join the conversation?
$STJ said that for FY16 the company continues to expect gross profit margin to be in the range of 69-69.5%, which includes the expectation of continued weakness in the US CRM business. R&D expenses in 1Q16 were 13% of net sales and for FY16 $STJ expects R&D expense to be in the range of 12.5-13% of net sales.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)